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A B S T R A C T
Aim. – Coffee consumption is inversely related to risk of type 2 diabetes (T2D). In contrast, an increased
risk of latent autoimmune diabetes in adults (LADA) has been reported in heavy coffee consumers,
primarily in a subgroup with stronger autoimmune characteristics. Our study aimed to investigate
whether coffee consumption interacts with HLA genotypes in relation to risk of LADA.
Methods. – This population-based study comprised incident cases of LADA (n = 484) and T2D (n = 1609),
and also 885 healthy controls. Information on coffee consumption was collected by food frequency
questionnaire. Odds ratios (ORs) with 95% CIs of diabetes were calculated and adjusted for age, gender,
BMI, education level, smoking and alcohol intake. Potential interactions between coffee consumption
and high-risk HLA genotypes were calculated by attributable proportion (AP) due to interaction.
Results. – Coffee intake was positively associated with LADA in carriers of high-risk HLA genotypes (OR:
1.14 per cup/day, 95% CI: 1.02–1.28), whereas no association was observed in non-carriers (OR: 1.04, 95%
CI: 0.93–1.17). Subjects with both heavy coffee consumption ( 4 cups/day) and high-risk HLA
genotypes had an OR of 5.74 (95% CI: 3.34–9.88) with an estimated AP of 0.36 (95% CI: 0.01–0.71;
P = 0.04370).
Conclusion. – Our ﬁndings suggest that coffee consumption interacts with HLA to promote LADA.
C 2018 Elsevier Masson SAS. All rights reserved.
Available online at
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Observational studies have consistently shown that coffee
consumption is associated with a reduced risk of type 2 diabetes
(T2D) [1]. The potentially protective effect has been attributed to
improvement of insulin sensitivity and glucose metabolism [2–4],
and reduced oxidative stress [5]. In contrast, an increased risk of
latent autoimmune diabetes in adults (LADA) was recently* Corresponding author at: Unit of Epidemiology, Institute of Environmental
Medicine (IMM), Karolinska Institutet, 171 77 Stockholm, Sweden.
E-mail address: bahareh.rasouli@ki.se (B. Rasouli).
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1262-3636/C 2018 Elsevier Masson SAS. All rights reserved.observed in heavy consumers of coffee [6], although the excess
risk was only apparent for LADA patients with high levels of
glutamic acid decarboxylase antibodies (GADA). Indeed, a positive
association between coffee intake and levels of GADA has been
observed [6].
Such a ﬁnding suggests that coffee either triggers or promotes
islet autoimmunity. This ﬁts with ﬁndings in adolescents with type
1 diabetes (T1D), and is also consistent with data on per capita
coffee consumption across different countries and incidence of T1D
[7,8]. However, those studies were hampered by small numbers [8]
and crude data [7]. Nevertheless, the impact of coffee intake on the
immune system and autoimmune diseases has been receiving, genetic susceptibility and risk of latent autoimmune diabetes in
8), https://doi.org/10.1016/j.diabet.2018.05.002
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increased risk of rheumatoid arthritis [10] as well as a reduced risk
of multiple sclerosis [11].
Human leucocyte antigen (HLA) haplotypes are strongly linked
to the development of autoimmune diabetes [12,13]. Autoimmune
diabetes-related HLA haplotypes are found in about 90% of children
with T1D [14], in 70% of patients with adult-onset autoimmune
diabetes [15] and in 37–53% of the general Caucasian population
[16,17]. However, as not all genetically susceptible individuals
develop autoimmune diabetes, environmental factors are likely to
be important in the initiation and/or progression of disease
[18]. Yet, whether coffee intake interacts with HLA genotypes has
not been previously explored. Thus, the aim of the present study
was to investigate the risk of LADA in relation to coffee intake,
using newly collected data from the same population as in our
previous study [6], but with almost twice as many cases and
including information on HLA genotypes associated with autoim-
munity [12–15].
Subjects and methods
Study population and design
The study was based on the Epidemiological Study of Risk
Factors for LADA and Type 2 Diabetes (ESTRID), a Swedish
population-based case-control study. Details of ESTRID have been
described elsewhere [6]. In short, ESTRID is a substudy of the All
New Diabetics in Scania (ANDIS) study (http://andis.ludc.med.lu.
se/) [19], an extensive study aimed at characterizing all new cases
of diabetes in southern Sweden. Since 2010, all newly diagnosed
patients with LADA have been invited to enrol in ESTRID. In 2012,
recruitment was expanded to All New Diabetics in Uppsala
(ANDIU; www.andiu.se/), a sister study to ANDIS in the county of
Uppsala (in the middle of Sweden). For each identiﬁed LADA
patient, four incident cases of T2D were randomly selected from
ANDIS/ANDIU and matched by date of participation.
Of the enrolled patients, 95% came from Scania and 5% from
Uppsala, for whom questionnaire and clinical and genetic
information was collected. Also, controls without diabetes
( 35 years of age, n = 1909) were randomly selected from the
national population register, which supplied questionnaire infor-
mation, although no blood samples were taken. For purposes of the
present study, data from population-based, randomly selected,
controls recruited from a sister study of rheumatoid arthritis, the
Epidemiological Investigation of Rheumatoid Arthritis (EIRA) [20],
were included. EIRA was carried out in the middle and southern
parts of Sweden according to a similar methodology as in ESTRID,
but with genetic information available.
The analytical sample for the present study comprised all
patients [LADA: n = 484 (465 from ANDIS, 19 from ANDIU); T2D:
n = 1609 (1519 from ANDIS, 90 from ANDIU)] included in ESTRID
from 2010 up to July 2017, with complete information on coffee
consumption and potential confounders, together with all controls
from EIRA, recruited from 2005 to 2009, with complete informa-
tion on coffee consumption, confounders and HLA genotypes
(n = 885). Of the cases, 48% were from our previous paper, which
was based on cases collected during 2010–2013 [6]. Ethics
approvals for both ESTRID and EIRA were obtained from the
relevant ethics committees in Stockholm, and all participants gave
their informed consent.
Coffee consumption and covariates
At the time of recruitment, patients (ESTRID) and controls
(ESTRID and EIRA) answered an extensive questionnaire that wasPlease cite this article in press as: Rasouli B, et al. Coffee consumption
adults: A population-based case-control study. Diabetes Metab (201identical as regards many items, including physical activity,
education and smoking, as well as a validated [21] food frequency
questionnaire (FFQ). Participants were asked to report their
average daily or weekly intake of coffee (brewed coffee, boiled
coffee and espresso, each type separately) over the past year.
Diabetes patients received the questionnaire soon after their
diagnosis and were speciﬁcally instructed to report their average
intakes for the year prior to diagnosis. While there was no question
regarding decaffeinated coffee, in Sweden, brewed coffee is the
most common type [22], accounting for 91% of the total coffee
intake in our study population, and consumption of decaffeinated
coffee is highly unusual [22].
Total daily coffee intake was calculated as the sum of coffee
consumption in number of cups (150 mL) per day. Also, the
nutrient intake of each food item in the FFQ was estimated by
multiplying frequency of consumption by nutrient content as per
the Swedish National Food Agency Database [23], taking into
account age-speciﬁc portion sizes [24]. Total energy intakes (kcal/
day) were also calculated. Body mass index (BMI) was self-
reported, and calculated as weight (in kg) divided by the square of
height (in m). Average alcohol intakes were categorized as none,
0.1–4.9, 5–14.9 or  15 g/day. Subjects were categorized into
current, former and never smokers. Highest achieved level of
education was categorized into three levels: low (primary school);
medium (upper secondary school); and high (university). Physical
activity was assessed by validated questions [25] about average
leisure-time physical activity during the preceding year with four
response options, ranging from sedentary to very active.
Deﬁnition of diabetes subtypes
At the time of diagnosis, blood samples were drawn from all
patients, and analyzed for GADA by enzyme-linked immunosor-
bent assay (Elisa) [26] and for C-peptide by the IMMULITE
2000 immunoassay system (Siemens Healthcare GmbH, Erlangen,
Germany) or by cobas 6000 e601 immunology analyzer (Roche
Diagnostics, Basel, Switzerland) [27]. In ANDIS and ANDIU, patients
aged  35 years at diabetes onset were classiﬁed as either LADA if
they were GADA-positive ( 10 IU/mL) with C-peptide  0.2 nmol/
L (IMMULITE)/or  0.3 nmol/L (cobas), or as T2D if they were
GADA-negative (< 10 IU/mL) with C-peptide > 0.6 nmol/L (IMMU-
LITE)/or > 0.72 nmol/L (cobas). C-peptide criteria in the deﬁnition
of T2D excludes those with relative insulin deﬁciency according to
the deﬁnitions used in ANDIS/ANDIU [28]. At a GADA cut-off of
10.7 IU/mL, sensitivity was 84% and speciﬁcity was 98% [26]. LADA
patients were also stratiﬁed according to median GADA levels
(< 233 and  233 IU/mL) into LADAlow and LADAhigh, respectively.
Homoeostasis model assessment to approximate insulin resistance
(HOMA-IR) and to estimate b-cell function (HOMA-b) were
calculated based on fasting plasma glucose and C-peptide [29].
Genetic analysis
At the Lund University Diabetes Centre, DNA was extracted
from blood samples taken of all study patients and analyzed
for > 300 different gene variants, using iPLEX Gold genotyping
technology (Sequenom, San Diego, CA, USA). Controls from EIRA
were genotyped for single-nucleotide polymorphisms (SNPs) using
the Inﬁnium Illumina 300K immunochip custom array (Illumina,
San Diego, CA, USA) [30]. The focus was on carriers of high-risk HLA
class-II DR/DQ genotypes, known to be associated with autoim-
mune diabetes [12]. Three SNPs in the major histocompatibility
complex (MHC) region (rs3104413, rs2854275, rs9273363), shown
to predict high-risk HLA DR/DQ genotypes relevant to autoimmune
diabetes with an overall accuracy of 99.3% [31], were available in
both ESTRID and EIRA. Combinations of these three SNPs were used, genetic susceptibility and risk of latent autoimmune diabetes in
8), https://doi.org/10.1016/j.diabet.2018.05.002
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DR4-DQ7, DR4/3-DQ8, DR4-DQ8, DRX/X and DQA1*0501-
DQB1*020. Genetic information was available for 83% of LADA
and 80% of T2D patients. Based on the prevalence of HLA risk
genotypes (Table S1; see supplementary materials associated with
this article online) in our study population and on previous
knowledge [14,15], subjects were categorized into high-risk HLA
genotypes (DR4-DQ8, DR4/3-DQ8, DR3/4, DR3/3, DR4/4, DQA1*0501-
DQB1*0201) [14,15,32,33] and other HLA genotypes (DR3/X, DR4/X,
DR4-DQ7, DRX/X) [32,34].
Statistical analysis
Characteristics of the participants were expressed as means,
proportions and medians (when data were skewed or inﬂuenced
by outliers). Two-tailed P values were calculated using Chi2
(proportions), Student’s t (means) and Kruskal–Wallis H (medians)
tests. Odds ratios (ORs) and 95% conﬁdence intervals (CIs) for the
association between coffee consumption and LADA or T2D were
calculated by conditional logistic regression. An association was
considered signiﬁcant if the 95% CI for an OR did not include the
null value of 1, which corresponds to a P value < 0.05 based on a
two-tailed test. In all analyses unless otherwise stated, controls
from EIRA were used and post-matched to ESTRID cases by age and
gender [35]. Coffee consumption was analyzed as continuous (cup/
day) and categorical variables. ORs of LADA and T2D were
estimated in relation to HLA genotypes, and stratiﬁed in analyses
by HLA genotype. The potential interaction between heavy coffee
consumption and high-risk HLA genotypes was deﬁned as any
departure from the additivity of effects [36], and evaluated by
calculating the attributable proportion (AP) due to interaction
together with a 95% CI [37]. All analyses were conditioned on age
and gender, and adjusted for BMI, alcohol consumption, smoking
status and education level unless otherwise speciﬁed. Further
adjustments for physical activity and total energy intakes did not
change the ORs (< 10%). All analyses were done with SAS version
9.4 software (SAS Institute, Cary, NC, USA).
Results
Participants’ characteristics
Mean age was 63 years in T2D patients, 59 years in LADA
patients and 57 years in controls (Table 1). Compared with T2DTable 1
Characteristics of study participants with type 2 diabetes (T2D), latent autoimmune di
Characteristics Controls 
Subjects, n 885 
Age, mean years (SD) 57 (9) 
Men, n (%) 239 (27) 
Low education level, n (%) 221 (25) 
BMI, mean kg/m2 (SD) 25.5 (4.2) 
Physically inactive, n (%) 115 (13) 
Current smokers, n (%) 171 (19) 
Low alcohol drinkers (< 5 g/day), n (%) 341 (38) 
Insulin treatment, n (%)b – 
C-peptide, median nmol/L (IQR)b – 
HOMA-IR, median (IQR)b – 
HOMA-b, median (IQR)b – 
GADA, median IU/mL (IQR)b – 
HbA1c, median mmol/mol (IQR)b – 
HLA high-risk genotype, n (%)c 280 (32) 
BMI: body mass index; IQR: interquartile range; HOMA-IR/b: homoeostasis model ass
antibodies; HLA: human leucocyte antigen.
a LADA vs. T2D patients.
b Data only available for T2D and LADA patients.
c Those with DR4-DQ8, DR3/4, DR3/3, DR4/4, DR4/3-DQ8, DQA1*0501-DQB1*0201 (o
Please cite this article in press as: Rasouli B, et al. Coffee consumption
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sedentary and of low education, but more likely to be treated with
insulin, and to have lower HOMA-b and HOMA-IR scores. High-risk
HLA genotypes were carried by 61% of LADA, 31% of T2D patients
and 32% of controls (Table 1), and were more prevalent in LADAhigh
(68%) than in LADAlow (54%) patients (Table S2; see supplementary
materials associated with this article online).
Comparison of the characteristics of EIRA controls (in the
present study) and controls collected from ESTRID (with no genetic
information) indicated they were similar with regard to many
characteristics (Table S3; see supplementary materials associated
with this article online). However, EIRA controls were younger and,
as a factor of study design, a greater number were female
(rheumatoid arthritis is more common in women) [20]. Differences
in age and gender were handled by post-matching.
Coffee consumption, T2D and LADA
There was a tendency towards an inverse relationship between
daily amounts of consumed coffee and T2D (Table 2): the OR for
every additional cup/day of coffee was estimated as 0.94 (95% CI:
0.89–1.00). Results were similar when the internal controls from
ESTRID were analyzed (OR: 0.92, 95% CI: 0.88–0.96 per cup/day).
However, overall coffee consumption was unrelated to LADA (OR:
1.05, 95% CI: 0.98–1.13 per cup/day; Table 2). Yet, stratifying
participants by HLA risk genotype revealed an association between
coffee consumption and LADA among carriers of high-risk HLA
genotypes (OR: 1.14 per cup/day, 95% CI: 1.02–1.28), whereas no
such association was seen among non-carriers (Table 2). Moreover,
the results were consistent when internal controls from ESTRID (no
genetic information) were used, and LADA cases were stratiﬁed by
HLA genotype (Table S4; see supplementary materials associated
with this article online). Stratiﬁcation of LADA patients by median
GADA levels (< 233 and  233 IU/mL) indicated that coffee intake
was associated with LADAhigh (OR: 1.10 per cup/day, 95% CI: 1.01–
1.20), but not with LADAlow (Table S5; see supplementary
materials associated with this article online).
Interaction between coffee consumption and HLA genotype
Carriers of high-risk HLA genotypes who were heavy consumers
of coffee ( 4 cups/day) had an OR of 5.74 (95% CI: 3.34–9.88) for
LADA compared with non-carriers with low coffee consumption
(< 2 cups/day; Fig. 1). Also, there was an additive interactionabetes in adults (LADA) and controls.
T2D LADA Pa
1609 484
63 (10) 59 (12) < 0.0001
983 (61) 259 (53) 0.0031
583 (36) 135 (28) 0.0007
31.1 (5.4) 28.1 (5.5) < 0.0001
380 (24) 82 (17) 0.0026
325 (20) 111 (23) 0.7872
823 (51) 230 (48) 0.1621
91 (6) 206 (44) < 0.0001
1.20 (0.95–1.60) 0.69 (0.43–1.13) < 0.0001
3.6 (2.7–4.8) 2.8 (1.8–4.4) < 0.0001
69 (43–94) 38 (14–68) < 0.0001
– 233 (28–250) –
51 (45–69) 64 (49–97) < 0.0001
400 (31) 243 (61) < 0.0001
essment of insulin resistance/b-cell function; GADA: glutamic acid decarboxylase
ther HLA genotypes: DR3/X, DR4/X, DR4-DQ7, DRX/X).
, genetic susceptibility and risk of latent autoimmune diabetes in
8), https://doi.org/10.1016/j.diabet.2018.05.002
Table 2
OR of LADA and type 2 diabetes in relation to coffee consumption.
Type 2 diabetes LADA
Overall Individuals with other
HLA genotypea
Individuals with high risk
HLA genotypea
No.
controls
No.
cases
ORb
(95% CI)
ORc
(95% CI)
No. cases ORb
(95% CI)
ORc
(95% CI)
Cases/controls ORc
(95% CI)
Cases/controls ORc
(95% CI)
Daily coffee consumption
< 2 cups 198 416 Reference Reference 108 Reference Reference 33/137 Reference 51/61 Reference
2–3 cups 406 650 0.66
(0.52–0.84)
0.73
(0.55–0.97)
192 0.89
(0.65–1.21)
1.01
(0.73–1.40)
69/279 1.21
(0.72–2.02)
88/127 1.11
(0.65–1.95)
4–5 cups 223 368 0.69
(0.53–0.90)
0.68
(0.49–0.94)
122 0.95
(0.67–1.35)
1.06
(0.73–1.53)
41/149 1.15
(0.64–2.05)
68/74 1.43
(0.79–2.57)
 6 cups 58 175 1.07
(0.74–1.56)
0.86
(0.54–1.36)
62 1.57
(0.98–2.52)
1.53
(0.92–2.52)
15/40 1.10
(0.48–2.53)
36/18 2.45
(1.12–5.35)
Per cup/day 885 1609 0.98
(0.93–1.03)
0.94
(0.89–1.00)
484 1.05
(0.98–1.13)
1.05
(0.98–1.13)
158/605 1.02
(0.93–1.12)
243/280 1.10
(1.01–1.20)
a High risk HLA genotype: Individuals with DR4-DQ8, DR3/4, DR3/3, DR4/4, DR4/3-DQ8, and DQA1*0501-DQB1*0201; Other HLA genotypes: individuals with DR3/X, DR4/X,
DR4-DQ7, and DRX/X.
b Conditioned on age, gender.
c Conditioned on age and sex, and adjusted for smoking, BMI, education, and alcohol consumption.
Fig. 1. Odds ratios (ORs) of latent autoimmune diabetes in adults (LADA) in relation to coffee consumption and human leucocyte antigen (HLA) risk genotypes. Data are
conditioned on age and gender, and adjusted for smoking, body mass index, and levels of education and alcohol consumption. ‘HLA risk: high’ refers to genotypes DR4-DQ8,
DR3/4, DR3/3, DR4/4, DR4/3-DQ8 and DQA1*0501-DQB1*0201; ‘HLA risk: Other’ refers to genotypes DR3/X, DR4/X, DR4-DQ7 and DRX/X.
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estimated as 0.36 (95% CI: 0.01–0.71; P = 0.04370; Table S6; see
supplementary materials associated with this article online).
Carriers of high-risk HLA genotypes and heavy coffee consumption
had an OR of 11.78 (95% CI: 5.39–25.77) for LADAhigh and OR of 3.02
(95% CI: 1.52–6.01) for LADAlow (Fig. S1; see supplementary
materials associated with this article online).
Coffee consumption, GADA, HOMA-IR and HOMA-b
On comparing median levels of HOMA indices, C-peptide and
GADA across categories of coffee consumption in LADA and T2D
patients (Table 3), it was noted that, in LADA, those with heavy
coffee intakes had lower levels of C-peptide and b-cell function. In
patients with T2D, levels of C-peptide and HOMA-IR were lower in
heavy coffee drinkers, whereas no clear difference was seen in
HOMA-b scores.Please cite this article in press as: Rasouli B, et al. Coffee consumption
adults: A population-based case-control study. Diabetes Metab (201Sensitivity analysis
In an attempt to evaluate the potential inﬂuence of different
time periods of recruitment into EIRA and ESTRID, an analysis was
performed that was restricted to only those patients and controls
recruited within the nearest time period of each other. This, which
involved only small numbers (181 controls, 2008–2009; 51 LADA
patients, 2009–2010), did not change the results (OR: 1.10 per cup/
day, 95% CI: 0.88–1.38). A separate analysis of only women with
high-risk HLA genotypes likewise produced similar results (OR:
1.12 per cup/day, 95% CI: 0.96–1.32).
Discussion
Our present study indicates that coffee consumption is
positively associated with LADAhigh and that coffee intake interacts, genetic susceptibility and risk of latent autoimmune diabetes in
8), https://doi.org/10.1016/j.diabet.2018.05.002
Table 3
Median (interquartile range, IQR) values for homoeostasis model assessment of insulin resistance (HOMA-IR) and b-cell function (HOMA-b), C-peptide and glutamic acid
decarboxylase antibodies (GADA) in patients with latent autoimmune diabetes in adults (LADA) and type 2 diabetes (T2D).
Coffee consumption Pa Pb
< 2 cups/day 2–3 cups/day  4 cups/day
LADA
Patients, n 108 192 184
HOMA-IR, median (IQR) 3.0 (2.0–4.7) 2.7 (1.8–4.0) 2.7 (1.8–4.4) 0.2386 0.2731
HOMA-b, median (IQR) 43 (16–76) 47 (17–76) 26 (12–52) 0.0173 0.0026
C-peptide, median nmol/L (IQR) 0.83 (0.45–1.30) 0.73 (0.47–1.20) 0.63 (0.37–1.00) 0.0060 0.0117
GADA, median IU/mL (IQR) 177 (33–250) 203 (24–250) 250 (30–250) 0.2416 0.4186
T2D
Patients, n 416 650 543
HOMA-IR, median (IQR) 3.7 (2.9–5.0) 3.5 (2.6–4.8) 3.5 (2.7–4.7) 0.0352 0.0257
HOMA-b, median (IQR) 70 (43–96) 68 (45–93) 68 (41–93) 0.4805 0.7681
C-peptide, median nmol/L (IQR) 1.30 (1.00–1.60) 1.20 (0.95–1.60) 1.20 (0.94–1.50) 0.0013 0.0050
a Lowest vs. highest categories of coffee consumption.
b Across different categories of coffee consumption.
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coffee intake is inversely associated with T2D [1].
These ﬁndings are based on incident cases of diabetes recruited
in Sweden between 2010 and 2017, and corroborate our previous
results based on patients recruited during 2010–2013 from the
same study [6]. Consistent with our results, Virtanen et al. [8]
observed an increased risk of T1D in adolescents who consumed
coffee regularly. While there do not appear to be any other studies
of the association between drinking coffee and autoimmune
diabetes, coffee consumption has been linked to an increased risk
of rheumatoid arthritis [10]. One possible explanation for such an
adverse effect of coffee could be the deleterious effects of some of
its compounds, such as caffeine and other alkaloids, on pancreatic
b cells as well as b-cell hyperstimulation, which might increase
the risk of activating b-cell autoimmunity [7,8,38]. This notion is
supported by our observation of poorer b-cell function (HOMA-b)
in LADA with heavy coffee consumption. Another potential
explanation is that exposure to coffee/caffeine might increase
proinﬂammatory markers that promote autoimmunity [39]. In line
with this hypothesis, our previous [6] and present ﬁndings indicate
that coffee consumption is associated with LADAhigh (the more
autoimmune form of LADA), but not LADAlow, which is more
similar to T2D [6].
An additive interaction was also observed between coffee
consumption and HLA risk genotypes associated with autoimmune
diabetes. No previous study has examined the coffee–gene
interaction in relation to autoimmune diabetes, although a strong
interaction between high-risk HLA variants and heavy coffee
intake has been found in rheumatoid arthritis [40]. However, the
mechanisms underlying the observed interaction are not clear. The
HLA risk genotypes [14,15] encoding antigens regulate autoim-
mune processes such as pathogenic T cells, which are involved in
autoimmune destruction of pancreatic b cells [41]. The resultant
triggering/exacerbation of autoimmune b-cell destruction by
environmental factors (for example, coffee intake) might then
be more pronounced in individuals carrying high-risk HLA
variants. This may also indicate that coffee and HLA risk genotypes
affect common biological pathways involved in the development
of autoimmune diabetes. Taken together, these data suggest that
the potential effects of coffee consumption may vary depending on
the genetic characteristics of the individual. Elaboration of the
precise mechanisms clearly require more investigation.
Nevertheless, studies have consistently shown that both
caffeinated and decaffeinated coffee consumption is inversely
related to T2D risk [1]. The reduced risk might be attributable to
the beneﬁcial effects of several compounds in coffee, such as
caffeine, chlorogenic acid, magnesium and lignans with antioxi-
dant properties [5], which might contribute to better glucosePlease cite this article in press as: Rasouli B, et al. Coffee consumption
adults: A population-based case-control study. Diabetes Metab (201metabolism and insulin sensitivity [2,4]. In line with this idea is our
observation that T2D patients with heavy coffee intakes are less
insulin-resistant and have lower levels of C-peptide.
Strengths of the present study include the population-based
design, large number of incident LADA cases, detailed information
on coffee consumption and large number of potential confounders,
including smoking, BMI, physical activity, total energy intake,
alcohol consumption and level of education. However, information
on coffee consumption was collected retrospectively, which may
have introduced bias if patients changed their consumption after
diagnosis and reported it accordingly. To minimize this problem,
patients answered the questionnaire as soon after their diagnosis
as possible and were instructed to report coffee consumption
as it was prior to diagnosis. Importantly, the Swedish diabetes
management guidelines include no recommendations regarding
coffee consumption [42].
One study limitation was the use of controls recruited from
another study (the EIRA). This was because no genetic information
was available for controls collected from ESTRID. However, all
controls were similar with regard to several characteristics,
although the EIRA controls were slightly younger, and the
proportion of women larger, compared with ESTRID controls. To
account for this, they were matched with our patients by age and
gender for the analyses [35]. Also, it is possible that some controls
may have had undiagnosed diabetes (primarily T2D), which would
have made them more similar to T2D cases in terms of coffee
consumption prevalence, thereby leading to overestimation of
the positive association between coffee consumption and LADA.
Bias could also have been introduced if coffee consumption of the
external controls did not reﬂect coffee consumption in the
population generating the diabetes patients. However, it is
noteworthy that the average daily coffee consumption in the
ESTRID (2.9 cups/day) and EIRA controls (2.8 cups/day) was
similar. Also, a similar positive association was found between
coffee intake and LADA with high-risk HLA genotypes when
internal controls from ESTRID were used. Nevertheless, the
recruitment periods of EIRA (2005–2009) and ESTRID (2009–
2016) differed and, if coffee consumption increased over time, this
would have led to overestimation of the association with LADA. In
fact, according to a report by the Swedish Board of Agriculture,
coffee consumption has remained largely constant since 1976
[43]. More important, with regard to T2D, our results were
consistent with those of numerous previous cohort studies,
thereby supporting the validity of the study [1]. As information
on family history of diabetes was unavailable for controls, this
could not be taken into account. However, adjusting for family
history of diabetes had little effect on the results of our previous
report [6]., genetic susceptibility and risk of latent autoimmune diabetes in
8), https://doi.org/10.1016/j.diabet.2018.05.002
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It appears that coffee intake is positively associated with LADA
among carriers of high-risk HLA genotypes. Thus, the potential role
of coffee in promoting autoimmunity warrants further investiga-
tion, given the widespread consumption of coffee.
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